Ep. 303 PARP Inhibitors: Clinical Trials & Real-World Applications with Dr. Neeraj Agarwal and Dr. Arun Azad
From BackTable Urology · · 1 hr 15 min
This plays from the publisher's own server. We do not host a copy.
Description
Keeping patients on PARP inhibitors long enough to see real benefit often comes down to proactive side effect management. In this episode of BackTable Urology, Dr. Neeraj Agarwal and Dr. Arun Azad join host Dr. Alan Tan to discuss practical, evidence-based strategies for managing hematologic and GI toxicities in advanced prostate cancer patients receiving PARP inhibitors.
---
Get the BackTable app https://www.backtable.com/app
---
This podcast is supported by an educational grant from Pfizer.
---
Timestamps
00:00 - Introduction 06:17 - Managing Anemia 11:12 - Side Effect Profiles 19:33 - Transfusions vs ESAs 26:43 - Docetaxel vs PARP Inhibitors 30:27 - Side Effect Management Pearls 40:18 - Team Based Monitoring 52:27 - Tissue Versus Liquid 01:01:24 - Genetic Counseling Workflow 01:07:07 - Trial Equity and Access
---
More about this episode
The doctors discuss the importance of close anemia monitoring during the critical first 3 to 4 months of therapy, maintaining dose intensity, proactive antiemetic use, and the role of exercise and resistance training in combating fatigue. The conversation also covers differences in toxicity profiles between PARP agents, the value of multidisciplinary care teams, molecular advances in molecular and germline testing, and the evolving landscape of emerging therapies in prostate care.
---
Resources
Talazoparib plus enzalutamide in men with metastatic castration-resistant prostate cancer: final overall survival results from the randomised, placebo-controlled, phase 3 TALAPRO-2 trial https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00684-1/abstract
BRCAAway: A randomized phase 2 trial of abiraterone, olaparib, or abiraterone + olaparib in patients with metastatic castration-resistant prostate cancer (mCRPC) bearing homologous recombination-repair mutations (HRRm). https://ascopubs.org/doi/10.1200/JCO.2024.42.4_suppl.19
---
BackTable Urology is the go-to podcast for urologists, urologic oncologists, and urogynecologists.
Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty.